Compare LECO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LECO | SNN |
|---|---|---|
| Founded | 1895 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 14.0B |
| IPO Year | N/A | 1999 |
| Metric | LECO | SNN |
|---|---|---|
| Price | $245.38 | $33.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | ★ $244.00 | $32.83 |
| AVG Volume (30 Days) | 368.9K | ★ 476.9K |
| Earning Date | 10-30-2025 | 03-02-2026 |
| Dividend Yield | 1.29% | ★ 2.19% |
| EPS Growth | 11.30 | ★ 59.91 |
| EPS | ★ 9.34 | 0.56 |
| Revenue | $4,176,319,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $7.92 | $7.78 |
| Revenue Next Year | $6.01 | $5.13 |
| P/E Ratio | ★ $26.28 | $29.10 |
| Revenue Growth | 3.24 | ★ 5.35 |
| 52 Week Low | $161.11 | $23.69 |
| 52 Week High | $249.19 | $38.79 |
| Indicator | LECO | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 65.20 | 48.01 |
| Support Level | $234.05 | $32.68 |
| Resistance Level | $242.17 | $33.56 |
| Average True Range (ATR) | 5.38 | 0.41 |
| MACD | 2.01 | 0.14 |
| Stochastic Oscillator | 95.32 | 78.51 |
Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. Its portfolio includes arc-welding solutions, plasma and oxy-fuel cutting systems, brazing and soldering alloys, and automation solutions. Lincoln Electric serves clients across general fabrication, heavy industries, automotive, construction, shipbuilding, energy, and process industries, among others. Based in Cleveland, Lincoln Electric operates in 19 countries and employs 11,000 worldwide. The company generated roughly $4 billion in sales in 2024.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.